Investing.com - Takeda Pharma ADR reported on Wednesday fourth quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Takeda Pharma ADR announced earnings per share of ¥0.0352 on revenue of ¥6.75B. Analysts polled by Investing.com anticipated EPS of ¥0.0606 on revenue of ¥6.94B.
Takeda Pharma ADR shares are up 6.53% from the beginning of the year and are trading at ¥14.52 , down-from-52-week-high.They are outperforming the EUR/USD which is down 0% from the start of the year.
Takeda Pharma ADR follows other major Healthcare sector earnings this month
Takeda Pharma ADR's report follows an earnings beat by J&J on Tuesday, April 19, 2022, who reported EPS of ¥2.67 on revenue of ¥23.43B, compared to forecasts EPS of ¥2.59 on revenue of ¥23.62B.
UnitedHealth had beat expectations on Thursday, April 14, 2022 with first quarter EPS of ¥5.49 on revenue of ¥80.15B, compared to forecast for EPS of ¥5.36 on revenue of ¥78.73B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar